RxDoctor Payments Data

Katie Griggs, PA

Physician Assistant · Lakeland, FLNPI 1376845859

Payments from drug & device makers

$1,346in general payments, 2019–2025

Across 72 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$303
  • Lilly USA, LLC$230
  • Novo Nordisk$169
  • Biohaven Pharmaceuticals, Inc.$114
  • Amgen$86
  • Madrigal Pharmaceuticals$67
  • plus $376 from 11 others

What the payments were for

  • Food & beverage$1,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,346 in reported general payments places this provider in the 65th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$18,533
Medicare patients
65
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$86,900
FarxigaDapagliflozin Propanediol49$70,220
EliquisApixaban27$42,105
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$37,328
JardianceEmpagliflozin25$27,937
Repatha SureclickEvolocumab26$23,144
SymbicortBudesonide/Formoterol Fumarate17$8,609
Celecoxib31$8,324
Gabapentin106$4,942
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$4,754
Albuterol Sulfate HfaAlbuterol Sulfate148$4,476
Duloxetine Hcl62$3,209
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate21$2,839
Varenicline Tartrate12$2,801
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,784

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$169$86,90056 claims
AstraZenecaFarxiga, Symbicort$54$78,82966 claims
PfizerEliquis$35$42,10527 claims
GSKTrelegy Ellipta$56$37,32833 claims
Boehringer IngelheimJardiance$37$27,93725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →